Leukemia Research
Volume 27, Issue 7 , Pages 583-591 , July 2003

Expression of TNF receptors and related signaling molecules in the bone marrow from patients with myelodysplastic syndromes

  • Masakazu Sawanobori

      Affiliations

    • Department of Pathology and Immunology, Aging and Developmental Sciences, Division of Gerontology and Gerodontology, Graduate School, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-ku, Tokyo 113-8519, Japan
    • Department of Internal Medicine, Japanese Red Cross Medical Center, 4-1-22 Hiroo, Shibuya-ku, Tokyo 150-0012, Japan
    • ,
  • Shuichi Yamaguchi

      Affiliations

    • Department of Pathology and Immunology, Aging and Developmental Sciences, Division of Gerontology and Gerodontology, Graduate School, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-ku, Tokyo 113-8519, Japan
    • ,
  • Maki Hasegawa

      Affiliations

    • Department of Molecular Pathophysiology, Moleculo-Genetic Sciences, Division of Biomedical Laboratory Sciences, Graduate School of Allied Health Sciences, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-ku, Tokyo 113-8519, Japan
    • ,
  • Miori Inoue

      Affiliations

    • Department of Pathology and Immunology, Aging and Developmental Sciences, Division of Gerontology and Gerodontology, Graduate School, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-ku, Tokyo 113-8519, Japan
    • ,
  • Kenshi Suzuki

      Affiliations

    • Department of Internal Medicine, Japanese Red Cross Medical Center, 4-1-22 Hiroo, Shibuya-ku, Tokyo 150-0012, Japan
    • ,
  • Ryuichi Kamiyama

      Affiliations

    • Department of Molecular Pathophysiology, Moleculo-Genetic Sciences, Division of Biomedical Laboratory Sciences, Graduate School of Allied Health Sciences, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-ku, Tokyo 113-8519, Japan
    • ,
  • Katsuiku Hirokawa

      Affiliations

    • Department of Pathology and Immunology, Aging and Developmental Sciences, Division of Gerontology and Gerodontology, Graduate School, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-ku, Tokyo 113-8519, Japan
    • ,
  • Masanobu Kitagawa

      Affiliations

    • Department of Pathology and Immunology, Aging and Developmental Sciences, Division of Gerontology and Gerodontology, Graduate School, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-ku, Tokyo 113-8519, Japan
    • Corresponding Author InformationCorresponding author. Tel.: +81-3-5803-5399; fax: +81-3-5803-0123.

Received 25 January 2002 ,Accepted 1 June 2002.

References 

  1. Delacretaz F, Schmidt P-M, Piguet D, Bachmann F, Costa J. The FAB classification (proposals) applied to bone marrow biopsy. Am. J. Clin. Pathol. 1987;87:180–186
  2. Jacobs A. Myelodysplastic syndromes: pathogenesis, functional abnormalities, and clinical implications. J. Clin. Pathol. 1985;38:1201–1217
  3. Harris NL, Jaffe ES, Diebold J, Flandrin G, Muller-Hermelink K, Vardiman J, et al.  World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the clinical advisory committee meeting, Airlie House, Virginia, November 1997. J. Clin. Oncol. 1999;17:3835–3849
  4. Parcharidou A, Raza A, Economopoulos T, Papageorgiou E, Anagnostou D, Papadaki T, et al.  Extensive apoptosis of bone marrow cells as evaluated by the in situ end-labelling (ISEL) technique may be the basis for ineffective haematopoiesis in patients with myelodysplastic syndromes. Eur. J. Haematol. 1999;62:19–26
  5. Fontenay-Roupie M, Bouscary D, Guesnu M, Picard F, Melle J, Lacombe C, et al.  Ineffective erythropoiesis in myelodysplastic syndromes: correlation with Fas expression but not with lack of erythropoietin receptor signal transduction. Br. J. Haematol. 1999;106:464–473
  6. Raza A, Mundle S, Shetty V, Alvi S, Chopra H, Span L, et al.  A paradigm shift in myelodysplastic syndromes. Leukemia. 1996;10:1648–1652
  7. Holm M, Hoyer M, jensen I, Thomsen M, Hokland P. Dynamic cell cycle kinetics in vitro and in vivo in myelodysplastic syndromes with special reference to the influence of hematopoietic growth factors. Leuk. Res. 2000;24:999–1008
  8. Kitagawa M, Yamaguchi S, Takahashi M, Tanizawa T, Hirokawa K, Kamiyama R. Localization of Fas and Fas ligand in bone marrow cells demonstrating myelodysplasia. Leukemia. 1998;12:486–492
  9. Raza A, Gezer S, Mundle S, Gao X-Z, Alvi S, Borok R, et al.  Apoptosis in bone marrow samples involving stromal and hematopoietic cells in 50 patients with myelodysplastic syndromes. Blood. 1995;86:268–276
  10. Kitagawa M, Saito I, Kuwata T, Yoshida S, Yamaguchi S, Takahashi M, et al.  Overexpression of tumor necrosis factor (TNF)-α and interferon (IFN)-γ by bone marrow cells from patients with myelodysplastic syndromes. Leukemia. 1997;11:2049–2054
  11. Gupta P, Niehans GA, LeRoy SC, Gupta K, Morrison VA, Schultz C. Fas ligand expression in the bone marrow in myelodysplastic syndromes correlates with FAB subtype and anemia and predicts survival. Leukemia. 1999;13:44–53
  12. Kitagawa M, Takahashi M, Yamaguchi S, Inoue M, Ogawa S, Hirokawa K, et al.  Expression of inducible nitric oxide synthase (NOS) in bone marrow cells of myelodysplastic syndromes. Leukemia. 1999;13:699–703
  13. Rosenfeld C, List A. A hypothesis for the pathogenesis of myelodysplastic syndromes: implications for new therapies. Leukemia. 2000;14:2–8
  14. Rossi G, Pelizzari AM, Bellotti D, Tonelli M, Barlatis S. Cytogenetic analogy between myelodysplastic syndrome and acute myeloid leukemia of elderly patients. Leukemia. 2000;14:636–641
  15. Willman CL. Molecular genetic features of myelodysplastic syndromes (MDS). Leukemia. 1998;12(Suppl 1):S2–S6
  16. DeSouza Fernandez T, Ornellas MH, Otero de Carvalho L, Tabak D, Abdelhay E. Chromosomal alterlations associated with evolution from myelodysplastic syndrome to acute myeloid leukemia. Leuk. Res. 2000;24:839–848
  17. Ogawa T, Kitagawa M, Hirokawa K. Age-related changes of human bone marrow: a histometric estimation of proliferative cells, apoptotic cells, T cells B cells and macrophages. Mech. Ageing Dev. 2000;117:57–68
  18. Utsuyama M, Hirokawa K, Kurashima C, Fukayama M, Inamatsu T, Suzuki K. Differential age-change in the number of CD4+CD45RA+ and CD4+CD29+ T cell subsets in the human peripheral blood. Mech. Ageing Dev. 1991;63:57–68
  19. Chang HN, Wang SR, Chiang SC, Teng WJ, Chen ML, Tsai JJ. The relationship of aged to endotoxin shock and to production of TNF-α. J. Gerontol. 1996;51:M220–222
  20. Ulich TR, del Castillo J, Guo K, Souza L. The hematologic effects of chronic administration of the monokines, tumor necrosis factor, interleukin-1, and granulocyte colony-stimulating factor on bone marrow and circulation. Am. J. Pathol. 1989;134:149–159
  21. Rusten LS, Jacobsen SE. Tumor necrosis factor (TNF)-α directly inhibits human erythropoiesis in vitro: role of p55 and p75 TNF receptor. Blood. 1995;85:989–996
  22. Sato T, Selleri C, Anderson S, Young NS, Maciejewski JP. Expression and modulation of cellular receptors for interferon-γ, tumor necrosis factor, and Fas on human bone marrow CD34+ cells. Br. J. Haematol. 1997;97:356–365
  23. Wiegmann K, Schutze S, Kampen E, Himmler A, Machllidt T, Kronke M. Human 55 kDa receptor for tumor necrosis factor coupled to signal transduction cascades. J. Immunol. 1992;267:17997–18001
  24. Hsu H, Xiong J, Goeddel DV. The TNF receptor-1 associated protein TRADD signal cell death and NF-κB activation. Cell. 1995;81:495–504
  25. Tartalia LA, Ayres TM, Wong GHW, Goeddle DV. A novel domain within the 55 kDa TNF receptor signals cell death. Cell. 1993;74:845–853
  26. Cheng G, Baltimore D. TANK a co-inducer with TRAF-2 of TNF- and CD40L-mediated NF-κB activatoin. Genes Dev. 1996;10:963–973
  27. Cheng G, Cleary AM, Ye Z, Hong DI, Lederman S, Baltimore D. Involvement of CRAF-1, a relative of TRAF, in CD40 signaling. Science. 1995;267:1494–1498
  28. Rothe M, Sarma V, Dixit VM, Goddel DV. TRAF-2 mediated activation of NF-κB by TNF receptor 2 and CD40. Science. 1995;269:1424–1427
  29. Rothe M, Wong SC, Henzel WJ, Goeddel DV. A novel family of putative signal transducers associated with the cytoplasmic domain of the 75 kDa tumor necrosis factor receptor. Cell. 1994;76:681–692
  30. Reinhard C, Shamoon B, Shyamala V, Williams LT. Tumor necrosis factor-α induced activation of c-jun N-terminal kinase mediated by TRAF-2. EMBO J. 1997;16:1080–1092
  31. Liu ZG, Hsu H, Goeddel DV, Karin M. Dissection of TNF receptor functions: JNK activation is not linked to apoptosis while NF-κB activation prevents cell death. Cell. 1996;87:565–576
  32. Natoli G, Costanzo A, Lanni A, Templeton DJ, Woodgett JR, Balsano C, et al.  Activation of SAPK/JNK by TNF receptor I through a non-cytotoxic TRAF-2 dependent pathway. Science. 1997;275:200–203
  33. Aggarwal S, Gollapudi S, Gupta S. Increased TNF-α-induced apoptosis in lymphocytes from aged humans: Changes in TNF-α receptor expression and activation of caspases. J. Immunol. 1999;162:2154–2161
  34. Rappolee DA, Mark D, Banda MJ, Werb Z. Wound macrophages express TNF-α and other growth factors in vivo: analysis by mRNA phenotyping. Science. 1988;241:708–712
  35. Kawasaki ES, Clark SS, Coyne MY, Smith SD, Champlin R, Witte ON, et al.  Diagnosis of chronic myeloid and acute lymphatic leukemias by detection of leukemia-specific mRNA sequences amplified in vitro. Proc. Natl. Acad. Sci. U.S.A. 1988;85:5698–5702
  36. Saito I, Servenius B, Compton T, Fox RI. Detection of Epstein–Barr virus DNA by polymerase chain reaction in blood and tissue biopsies from patients with Sjögren’s syndrome. J. Exp. Med. 1989;169:2191–2198
  37. Funk JO, Walczak H, Voigtlander C, Berchtold S, Baumeister T, Rauch P, et al.  Cutting edge: resistance to apoptosis and continuous proliferation of dendritic cells deficient for TNF receptor-1. J. Immunol. 2000;165:4792–4796
  38. Boudard D, Sordet O, Vasselon C, Revol V, Bertheas MF, Freyssenet D, et al.  Expression and activity of caspases 1 and 3 in myelodysplastic syndromes. Leukemia. 2000;14:2017–2018
  39. Bouscary D, Chen YL, Guesnu M, Picard F, Viguier F, Lacombe C, et al.  Activity of the caspase-3 /CPP32 enzyme is increased in “early stage” myelodysplastic syndromes with excessive apoptosis, but caspase inhibition does not enhance colony formation in vitro. Exp. Hematol. 2000;28:784–791
  40. Park A, Baichwal VR. Systematic mutational analysis of the death domain of the tumor necrosis factor receptor-1-associated protein TRADD. J. Biol. Chem. 1996;271:9858–9862
  41. Et Yeh W-C, Shahinian A, Speiser D, Kraunus J, Billia F, Wakeham A, et al.  Early lethality, functional NF-κB activation and increased sensitivity to TNF-induced cell death in TRAF-2 deficient mice. Immunity. 1997;7:715–725
  42. Gersuk GM, Beckham C, Loken MR, Kiener P, Anderson JE, Farrand A, et al.  A role for tumor necrosis factor-α, Fas and Fas-ligand in marrow failure associated with myelodysplastic syndrome. Br. J. Haematol. 1998;103:176–188
  43. Dar S, Mundle S, Andric T, Qawi H, Shetty V, Reza S, et al.  Biological characteristics of myelodysplastic syndrome patients who demonstrated high versus no intramedullary apoptosis. Eur. J. Haematol. 1999;62:90–94
  44. Ashkenazi A, Dixit VM. Death receptors: signaling and modulation. Science. 1998;281:1305–1308
  45. Mundle SD, Reza S, Ali A, Mativi Y, Shetty V, Venugopal P, et al.  Correlation of tumor necrosis factor alpha (TNF-α) with high Caspase 3-like activity in myelodysplastic syndromes. Cancer Lett. 1999;140:201–207
  46. Mundle SD, Ali A, Cartlidge JD, Reza S, Alvi S, Showel MM, et al.  Evidence for involvement of tumor necrosis factor-α in apoptotic death of bone marrow cells in myelodysplastic syndromes. Am. J. Hematol. 1999;60:36–47
  47. Thome M, Tschopp J. Regulation of lymphocyte proliferation and death by FLIP. Nat. Rev. Immunol. 2001;1:50–58
  48. Baud V, Karin M. Signal transduction by tumor necrosis factor and its relatives. Trends Cell Biol. 2001;11:372–377
  49. Mundle SD, Raza A. Defining the dynamics of self-assembled Fas-receptor activation. Trends Immunol. 2002;23:187–194
  50. Van Eijk M, Defrance T, Hennino A, de Groot C. Death-receptor contribution to the germinal-center reaction. Trends Immunol. 2001;22:677–682

PII: S0145-2126(02)00095-4

doi: 10.1016/S0145-2126(02)00095-4

Leukemia Research
Volume 27, Issue 7 , Pages 583-591 , July 2003

Article Tools

* Image Usage & Resolution